Today: 17 December 2025
Subscribe
Browse Category

Analyst Insights News 10 December 2025 - 12 December 2025

Mastercard (MA) Stock News Today: $14B Buyback, Dividend Hike, and Analyst Targets — What Investors Are Watching on Dec. 12, 2025

Mastercard (MA) Stock News Today: $14B Buyback, Dividend Hike, and Analyst Targets — What Investors Are Watching on Dec. 12, 2025

Mastercard stock has been in focus after the company announced a bigger dividend and a new $14 billion share repurchase authorization. Here’s the latest MA stock news, analyst forecasts, and key risks investors are tracking. Mastercard Incorporated (NYSE: MA) is
12 December 2025
 ·  ·  ·  · 
Costco Stock (COST) Outlook on Dec. 12, 2025: Earnings Beat, Analyst Price Targets, Tariff Risks, and What Comes Next

Costco Stock (COST) Outlook on Dec. 12, 2025: Earnings Beat, Analyst Price Targets, Tariff Risks, and What Comes Next

December 12, 2025 — Costco Wholesale Corporation (NASDAQ: COST) is back in the spotlight after posting a fiscal first-quarter 2026 earnings beat, renewing debate over whether the warehouse giant’s premium valuation is still justified as growth normalizes and tariff uncertainty
12 December 2025
 ·  ·  ·  ·  · 
Robinhood Stock (HOOD) Slides on Softer November Volumes: What the Latest Data, Analyst Forecasts, and New Catalysts Mean (Dec. 12, 2025)

Robinhood Stock (HOOD) Slides on Softer November Volumes: What the Latest Data, Analyst Forecasts, and New Catalysts Mean (Dec. 12, 2025)

Robinhood Markets, Inc. (NASDAQ: HOOD) is ending the week in the spotlight after a sharp pullback tied to the company’s latest monthly operating snapshot—and a wave of fresh analyst commentary that’s resetting expectations for 2026. As of 13:12 UTC on
12 December 2025
 ·  ·  ·  ·  · 
GSK Stock News Today (Dec. 12, 2025): Arexvy EU Expansion, Blujepa FDA Approval, Analyst Forecasts and What’s Next

GSK Stock News Today (Dec. 12, 2025): Arexvy EU Expansion, Blujepa FDA Approval, Analyst Forecasts and What’s Next

Published: 12 December 2025 GSK plc stock is back in focus on Friday as investors digest a fast-moving cluster of regulatory headlines across vaccines, infectious diseases and oncology—alongside ongoing buybacks and fresh consensus forecasts that map out how GSK’s revenue
12 December 2025
 ·  ·  ·  ·  · 
Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stock is on a tear. On 11 December 2025, shares surged to a new all‑time high after the company reported encouraging mid‑stage data in Prader‑Willi syndrome (PWS) and investors refocused on a growing obesity franchise
11 December 2025
 ·  ·  ·  ·  · 
Salesforce (CRM) After-Hours on December 10, 2025: Agentforce Momentum, Analyst Targets, and What to Watch Before the December 11 Open

Salesforce (CRM) After-Hours on December 10, 2025: Agentforce Momentum, Analyst Targets, and What to Watch Before the December 11 Open

Salesforce, Inc. (NYSE: CRM) stayed in focus on Wednesday as investors continued to digest its AI-heavy Q3 earnings story, a string of fresh product announcements, and active options and analyst activity. Here’s a concise but detailed look at where the
11 December 2025
 ·  ·  ·  ·  · 
Marvell Technology (MRVL) Stock Jumps on AI Connectivity Bets: Latest News, Earnings and Analyst Targets as of December 10, 2025

Marvell Technology (MRVL) Stock Jumps on AI Connectivity Bets: Latest News, Earnings and Analyst Targets as of December 10, 2025

Marvell Technology, Inc. (NASDAQ: MRVL) finds itself right in the middle of the AI-infrastructure arms race – and the stock is reacting accordingly. On Wednesday, December 10, 2025, Marvell shares traded around the low-$90s, up roughly 3% intraday, recovering from
10 December 2025
 ·  ·  ·  ·  · 
1 … 3 4 5 6 7 … 10
Go toTop